This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Hospira Infusion Pumps Ranked Top Devices In New KLAS Smart Pumps 2012 Report

LAKE FOREST, Ill., April 12, 2012 /PRNewswire/ -- Hospira, Inc. (NYSE: HSP), the world's leading provider of injectable drugs and infusion technologies, today announced its Symbiq and LifeCare PCA infusion pumps have been ranked as the top devices in their categories in the KLAS report, Smart Pumps 2012: Wireless Technology and EMR Integration Report . Hospira was also recognized as the "early leader" in electronic medical record (EMR) integration with infusion pumps. The rankings are based on data from customer surveys of North American hospital and clinic executives, administrators, physicians, nurses, clinicians, and other directors and managers interacting with healthcare equipment and infrastructure solutions. 

"Hospira is proud to be recognized for its advances in smart pump technology, patient safety, medication delivery and caregiver efficiency," said Thomas Moore, president, United States, Hospira. "As the leader in infusion technologies and I.V. clinical integration (I.V.C.I), Hospira focuses on delivering quality technology and services to our customers across our entire smart pump offering."

The Symbiq infusion device, considered the leader in its market segment, scored the highest overall performance rating (81.7)[1] for large volume pumps (LVPs). LifeCare PCA, also deemed a leading pump, scored the highest overall performance rating for patient-controlled analgesia pumps (PCAs) with a score of 81.1.

The Symbiq infusion system is a technologically advanced infusion device with clinician-friendly features designed to help improve workflow and decrease medication errors. With  Hospira MedNet™ safety software built into the device, Symbiq was the first general infusion system developed to provide additional medication-error protection by requiring users to select a drug library entry from the safety software for all drug delivery programs. Due to its highly sophisticated technology, Symbiq is one of the first devices to achieve I.V.C.I. of infusion pumps with EMRs.

To learn how WellSpan Health is using I.V.C.I. with full auto-programming technology to advance its focus on providing exceptional care, view this video: I.V. Clinical Integration: WellSpan Health.

The Symbiq infusion device was the only smart pump with a significant score increase in the past year, as all measured areas saw increased satisfaction. The KLAS smart pump 2012 report praised Symbiq for newer, more advanced technology. Symbiq infusion pumps have the highest-reported safety software drug library compliance among LVPs, at 93 percent.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $93.64 0.00%
FB $118.57 0.00%
GOOG $698.21 0.00%
TSLA $241.80 0.00%
YHOO $36.53 0.00%


Chart of I:DJI
DOW 17,891.16 +117.52 0.66%
S&P 500 2,081.43 +16.13 0.78%
NASDAQ 4,817.5940 +42.2360 0.88%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs